Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Finished Goods (2016 - 2020)

Trinity Biotech (TRIB) has disclosed Finished Goods for 5 consecutive years, with $12.9 million as the latest value for Q4 2020.

  • Quarterly Finished Goods rose 3.66% to $12.9 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $12.9 million through Dec 2020, up 3.66% year-over-year, with the annual reading at $12.9 million for FY2020, 3.66% up from the prior year.
  • Finished Goods hit $12.9 million in Q4 2020 for Trinity Biotech, up from $12.4 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $16.1 million in Q4 2016 to a low of $11.6 million in Q4 2018.
  • Historically, Finished Goods has averaged $13.6 million across 5 years, with a median of $12.9 million in 2020.
  • Biggest five-year swings in Finished Goods: dropped 24.04% in 2018 and later rose 7.46% in 2019.
  • Year by year, Finished Goods stood at $16.1 million in 2016, then dropped by 5.59% to $15.2 million in 2017, then fell by 24.04% to $11.6 million in 2018, then increased by 7.46% to $12.4 million in 2019, then grew by 3.66% to $12.9 million in 2020.
  • Business Quant data shows Finished Goods for TRIB at $12.9 million in Q4 2020, $12.4 million in Q4 2019, and $11.6 million in Q4 2018.